Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
Virus Evolution|September 17, 2021
RV144 vaccine imprinting constrained HIV-1 evolution following breakthrough infectionEric Lewitus, Eric Sanders-Buell, Meera Bose, et al.
Science Translational Medicine|April 2, 2025
Ebola virus vaccination elicits Ebola virus-specific immune responses without substantial cross-reactivity to other filovirusesThembi Mdluli, Suzanne Wollen-Roberts, Mélanie Merbah, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 19, 2024
Prevention efficacy of the broadly neutralizing antibody VRC01 depends on HIV-1 envelope sequence featuresMichal Juraska, Hongjun Bai, Allan C deCamp, et al.
Plos One|November 18, 2017
Sieve analysis of breakthrough HIV-1 sequences in HVTN 505 identifies vaccine pressure targeting the CD4 binding site of Env-gp120Allan C deCamp, Morgane Rolland, Paul T Edlefsen, et al.
Biorxiv : the Preprint Server for Biology|July 17, 2025
Influence of the broadly neutralizing antibody VRC01 on HIV breakthrough virus populations in antibody-mediated prevention trialsCarolyn Williamson, Chivonne Moodley, Craig A Magaret, et al.
Cell Reports|August 10, 2023
Zika-specific neutralizing antibodies targeting inter-dimer envelope epitopesRajeshwer S Sankhala, Vincent Dussupt, Gina Donofrio, et al.
Nature Communications|April 3, 2026
Influence of the broadly neutralizing antibody VRC01 on HIV breakthrough virus populations in antibody-mediated prevention trialsCarolyn Williamson, Chivonne Moodley, Craig A Magaret, et al.
Nature Communications|February 3, 2023
Shark nanobodies with potent SARS-CoV-2 neutralizing activity and broad sarbecovirus reactivityWei-Hung Chen, Agnes Hajduczki, Elizabeth J Martinez, et al.
Structure (London, England : 1993)|December 29, 2023
Antibody targeting of conserved sites of vulnerability on the SARS-CoV-2 spike receptor-binding domainRajeshwer S Sankhala, Vincent Dussupt, Wei-Hung Chen, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
VRC01 Selects Rare HIV Escape Mutations After Acquisition in Antibody-Mediated Prevention TrialsCarolyn Williamson, Lyle Curry, Nonhlanhla N Mkhize, et al.
Pageof 5